Citation: Wj. Burman et Rr. Reves, Hepatotoxicity from rifampin plus pyrazinamide - Lessons for policymakers and messages for care providers, AM J R CRIT, 164(7), 2001, pp. 1112-1113
Citation: Wj. Burman et Be. Jones, Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy, AM J R CRIT, 164(1), 2001, pp. 7-12
Citation: Tc. Stoeckli et Wj. Burman, Inactivated pronase as the cause of false-positive results of serum cryptococcal antigen tests, CLIN INF D, 32(5), 2001, pp. 836-837
Authors:
Zhu, M
Burman, WJ
Jaresko, GS
Berning, SE
Jelliffe, RW
Peloquin, CA
Citation: M. Zhu et al., Population pharmacokinetics of intravenous and intramuscular streptomycin in patients with tuberculosis, PHARMACOTHE, 21(9), 2001, pp. 1037-1045
Citation: Wj. Burman et Rt. Schooley, The role of local institutional review boards in protecting human researchsubjects, J AM MED A, 285(21), 2001, pp. 2713-2713
Authors:
Breese, PE
Burman, WJ
Hildred, M
Stone, B
Wilson, ML
Yang, ZH
Cave, MD
Citation: Pe. Breese et al., The effect of changes in laboratory practices on the rate of false-positive cultures for Mycobacterium tuberculosis, ARCH PATH L, 125(9), 2001, pp. 1213-1216
Citation: Wj. Burman et al., Breaking the camel's back: Multicenter clinical trials and local institutional review boards, ANN INT MED, 134(2), 2001, pp. 152-157
Authors:
Villarino, ME
Brennan, MJ
Nolan, CM
Catanzaro, A
Lundergan, LL
Bock, NN
Jones, CL
Wang, YC
Burman, WJ
Citation: Me. Villarino et al., Comparison testing of current (PPD-SI) and proposed (PPD-S2) reference tuberculin standards, AM J R CRIT, 161(4), 2000, pp. 1167-1171
Citation: Wj. Burman et Rr. Reves, Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment, CLIN INF D, 31(6), 2000, pp. 1390-1395
Citation: Be. Lundberg et al., Epidemiology of Pneumocystis carinii pneumonia in an era of effective prophylaxis: the relative contribution of non-adherence and drug failure, AIDS, 14(16), 2000, pp. 2559-2566
Authors:
El-Sadr, WM
Burman, WJ
Grant, LB
Matts, JP
Hafner, R
Crane, L
Zeh, D
Gallagher, B
Mannheimer, SB
Martinez, A
Gordin, F
Citation: Wm. El-sadr et al., Discontinuation of prophylaxis against Mycobacterium avium complex diseasein HIV-infected patients who have a response to antiretroviral therapy., N ENG J MED, 342(15), 2000, pp. 1085-1092
Citation: Wj. Burman et al., Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis, CLIN INF D, 28(3), 1999, pp. 419-429